Bahleda, Rastilav External Entity

Publications

Sort by

Selected publications

  • TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma.  Nature communications. 2016 In Process GET IT
    Times cited: 3

Other